The invention provides methods for improving the efficacy and reducing side effects of anti-CD52 antibody treatment. The methods can be used to treat patients who are in need of immunoregulation such as lymphocyte depletion and patients who have cancer. Also included are compositions useful for these methods.
申请公布号
WO2010132697(A2)
申请公布日期
2010.11.18
申请号
WO2010US34780
申请日期
2010.05.13
申请人
GENZYME CORPORATION;KAPLAN, JOHANNE, M.;ROBERTS, BRUCE, L.;SIDERS, WILLIAM, M.
发明人
KAPLAN, JOHANNE, M.;ROBERTS, BRUCE, L.;SIDERS, WILLIAM, M.